Vanguard Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q3 | $12.3M | Buy |
|
|||||
|
2022
Q2 | $6.69M | Buy |
|
|||||
|
2022
Q1 | $2.96M | Sell |
|
|||||
|
2021
Q4 | $3.83M | Sell |
|
|||||
|
2021
Q3 | $4.05M | Sell |
|
|||||
|
2021
Q2 | $5.22M | Sell |
|
|||||
|
2021
Q1 | $6.94M | Buy |
|
|||||
|
2020
Q4 | $16.4M | Buy |
|
|||||
|
2020
Q3 | $12.4M | Sell |
|
|||||
|
2020
Q2 | $12.6M | Buy |
|
|||||
|
2020
Q1 | $10.7M | Buy |
|
|||||
|
2019
Q4 | $9.65M | Sell |
|
|||||
|
2019
Q3 | $6.18M | Buy |
|
|||||
|
2019
Q2 | $12.1M | Buy |
|
|||||
|
2019
Q1 | $11.6M | Sell |
|
|||||
|
2018
Q4 | $12.4M | Sell |
|
|||||
|
2018
Q3 | $18.2M | Buy |
|
|||||
|
2018
Q2 | $19.1M | Buy |
|
|||||
|
2018
Q1 | $24.7M | Buy |
|
|||||
|
2017
Q4 | $20.1M | Buy |
|
|||||
|
2017
Q3 | $10.9M | Sell |
|
|||||
|
2017
Q2 | $10.6M | Buy |
|
|||||
|
2017
Q1 | $11.6M | Buy |
|
|||||
|
2016
Q4 | $6.62M | Buy |
|
|||||
|
2016
Q3 | $6.33M | Buy |
|
|||||
|
2016
Q2 | $6.81M | Buy |
|
|||||
|
2016
Q1 | $7.96M | Buy |
|
|||||
|
2015
Q4 | $10.2M | Buy |
|
|||||
|
2015
Q3 | $9.79M | Buy |
|
|||||
|
2015
Q2 | $6.3M | Buy |
|
|||||
|
2015
Q1 | $5.55M | Buy |
|
|||||
|
2014
Q4 | $4.67M | Sell |
|
|||||
|
2014
Q3 | $5.13M | Buy |
|
|||||
|
2014
Q2 | $796K | Buy |
|
|||||
|
2014
Q1 | $467K | Buy |
|